Free Trial
OTCMKTS:CLXPF

Cybin (CLXPF) Stock Price, News & Analysis

Cybin logo
$7.94 +0.56 (+7.59%)
As of 07/3/2025

About Cybin Stock (OTCMKTS:CLXPF)

Key Stats

Today's Range
$7.55
$7.97
50-Day Range
$6.08
$9.00
52-Week Range
$0.49
$3.38
Volume
442,098 shs
Average Volume
551,962 shs
Market Capitalization
$1.18 billion
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive CLXPF Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Cybin and its competitors with MarketBeat's FREE daily newsletter.

CLXPF Stock News Headlines

Cybin (OTCMKTS:CLXPF) Stock Price Up 7.3% - Here's Why
Cybin gears up for Phase 3 trial in depression treatment
A new rule goes live in July — and the banks are quietly cashing in
A little-known regulation quietly goes into effect this July. And it's already being exploited by Wall Street and the Big Banks… It gives them the green light to treat a certain tangible asset as equivalent to cold, hard cash. Not stocks. Not real estate. And definitely not the U.S. dollar. We're talking about something they don't want you to notice — because the fewer people who act on this, the better it is for them.
CYBN Stock Earnings: Cybin Beats EPS for Q1 2024
CYBN Stock Earnings: Cybin Beats EPS for Q4 2023
See More Headlines

CLXPF Stock Analysis - Frequently Asked Questions

Cybin's stock was trading at $8.82 at the start of the year. Since then, CLXPF shares have decreased by 10.0% and is now trading at $7.94.

Shares of CLXPF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Industry, Sector and Symbol

Stock Exchange
OTCMKTS
Sector
Medical
Industry
Holding & Other Investment Offices
Sub-Industry
Pharmaceutical Products
Current Symbol
OTCMKTS:CLXPF
CIK
N/A
Fax
N/A
Employees
50
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
$680 thousand
Price / Cash Flow
N/A
Book Value
$0.44 per share
Price / Book
18.05

Miscellaneous

Free Float
N/A
Market Cap
$1.18 billion
Optionable
Not Optionable
Beta
N/A
20 Stocks to Sell Now Cover

Today, we are inviting you to take a free peek at our proprietary, exclusive, and up-to-the-minute list of 20 stocks that Wall Street's top analysts hate.

Many of these appear to have good fundamentals and might seem like okay investments, but something is wrong. Analysts smell something seriously rotten about these companies. These are true "Strong Sell" stocks.

Get This Free Report

This page (OTCMKTS:CLXPF) was last updated on 7/7/2025 by MarketBeat.com Staff
From Our Partners